http://thesaker.is/ukraine-turkey-and-isis-overview-sitrep-2015-2016/
--
Concerning, very concerning we are also R1a1. Probably same virus deployed/tested here too.
--
Finally, there is a very interesting development with the state of Ukraine’s healthcare. In
December 2015, Ukraine and especially its southern regions of Odessa and Kharkov, started experiencing a deadly flu epidemic. About 6% of the Ukrainian population suffers from the unusual deadly flue virus H3N2 and H1N1, which is swine flu that takes two days, turns into severe pneumonia and death. [
source]
People ask questions, like: Have NATO bio labs located in Kharkov and Odessa released H3N2 flu virus? Hundreds have died in December only. It takes about two days for an infected person to die. The majority of dead are men. Hospitals and emergency rooms are filled beyond capacity, many schools are closed. Some towns declared the state of emergency. Ukrainian media is completely silent on the matter, along with the Kiev junta. People are writing to the Russia’s media, asking to interfere and to prevent the population from dying out. The elevated level of mortality is being seen in Odessa, Kiev and Kiev region, Kharkov, and Vinnitsa.
Irena Sysoeva, the member of parliament for healthcare, writes on her FB page that 5.7% of population are effected, 70% of all infected are pregnant women and children. Kiev authorities have been silent on the matter. Officially 25 people died of flu in December. Unofficially, many hundreds.
It could be that Americans are developing new biological weapon against Russians. Genetically, Russians in Russia and in Novorossia are identical. 50% is Haplogroup R1a1, and 20-25% I1 , I2. That’s why NATO labs located in Odessa and Kharkov. Are they making a bio “gift” for Russia?
The significant spike in the European and American clinical trials on humans in Ukraine confirms the worst.
EBA – The European Business Association, Ukraine. was proud to co-organize one of the biggest clinical trials conference in Ukraine in November 2015.
Clinical Trials Subcommittee of the Health Care Committee of EBA
The Clinical Trials Subcommittee unites R&D (Research and Development) pharmaceutical companies and CROs (Contract Research Organizations).
The main activities of the Subcommittee are focused on conducting
clinical trials in Ukraine and the harmonization of local regulations through cooperation with state bodies.
Clinical Trials
Clinical trials investigate the effects of medicines by testing them on humans. Clinical trials are an essential stage in the development of new treatments, and they also have a wide range of benefits for patients and the state.
On November 20th, 2015 the 5th Scientific Conference ‘
Clinical Trials in Ukraine’
took place. The Conference was organized by the State Enterprise ‘State Expert Center
of the Ministry of Health of Ukraine’ (SEC) and the European Business Association Clinical Trials Subcommittee
The Conference was supported by the Ministry of Health of Ukraine (MoH) and the National Academy of Medical Sciences of Ukraine.
This event gathered over 680 clinical trial professionals, medical doctors and scientists from Ukraine, and international experts from the Czech Republic, Poland, Lithuania, and Austria presented such reports as:
Clinical Research in Europe: Changes and Development Strategy by Magdalena Matusiak
Designs for BE Studies, Sample Size Estimation for BE Studies (Helmut Schutz, BEBAC)
Planning, Design Bioequivalence Studies, Statistics(Maryka Pechena, Quinta Analytica)
Ethical Review in the EU: REGULATION (EU) No 536/2014 (Eugenijus Gefenas, Lithuanian Bioethics Committee, EUREC).
The organizations of this conference are very proud that “the application rate for clinical trials has increased since mid 2015”
The application rate for clinical trials has increased since mid 2015 (please see the table below).
This positive trend, inter alia ,is caused by significant improvement of the regulatory and fiscal environment for clinical trials operations in Ukraine:
• import VAT rate for investigational products was reduced from 20% to 7%
• import permits were abolished
• regulatory approval timeframe was reduced from 60 to 55 days
• study submission procedures were simplified
• verification procedure of the insurance agreement text was simplified.
See also,
American flu kills Ukrainians [
source]